Akinobu Gotoh1, Toshiro Shirakawa, Yoshitaka Wada
1International Center for Medical Research, Kobe University School of Medicine.
Researchers developed a novel suicide-gene therapy for prostate cancer using organ-specific vectors. This approach, targeting bone metastasis, has shown safety in clinical trials and offers promise for systemic anti-tumor treatment.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Area of Science:
Context:
Purpose:
Summary:
Impact: